Photodynamic therapy in dermatology: Current concepts in the treatment of skin cancer

Expert Review of Anticancer Therapy

Volumn 5, Issue 5, 2005, Pages 791-800

  Garcia Zuazaga, Jorge ^a   Cooper, Kevin D ^a   Baron, Elma D ^b  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

Author keywords

Aminolevulinic acid; Photodynamic therapy; Photosensitizer; Skin cancer

Indexed keywords

ACRIDINE ORANGE; AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER; ANALGESIC AGENT; BEXAROTENE; CORTICOSTEROID; CYTOTOXIC AGENT; EOSIN; FLUOROURACIL; HEMATOPORPHYRIN; IMIQUIMOD; IMMUNOMODULATING AGENT; INTERFERON; OXYGEN; PHOTOFRIN; PHOTOSENSITIZING AGENT; PHTHALOCYANINE;

ACNE VULGARIS; ACTINIC KERATOSIS; BASAL CELL CARCINOMA; BLUE LIGHT; BOWEN DISEASE; BURNING SENSATION; CELL DESTRUCTION; CLINICAL TRIAL; DERMATOLOGY; DRUG APPROVAL; DRUG FORMULATION; DRUG MECHANISM; DRUG PENETRATION; ERYTHEMA; ESTHETICS; EUROPE; FOOD AND DRUG ADMINISTRATION; HUMAN; HYPERPIGMENTATION; LIGHT IRRADIANCE; MUTAGENICITY; PAIN; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PHOTOSTIMULATION; PSORIASIS; REVIEW; SKIN CANCER; SKIN EDEMA; SKIN LYMPHOMA; SKIN MANIFESTATION; T CELL LYMPHOMA;

AMINOLEVULINIC ACID; CARCINOMA, BASAL CELL; CLINICAL TRIALS; HUMANS; KERATOSIS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SKIN NEOPLASMS;

EID: 27744441485     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/14737140.5.5.791     Document Type: Review

References (46)

1. Cerbukov O, Gollnick H. Photodynamic therapy in dermatology. Euro. J. Derm. 10(7), 568-576 (2000).
2. Cappugi P, Campolmi P, Mavilia L, Prignano F, Rossi R. Topical 5-aminolevulinic acid and photodynamic therapy in dermatology: a minireview. J. Chemother. 13(5), 494-502 (2001).
3. Taub AF. Photodynamic therapy in dermatology: history and horizons. J. Drugs Dermatol. 3(Suppl. 1), S8-S25 (2004).
4. Hamzavi I, Lui H. Using light in dermatology: an update on lasers, ultraviolet phototherapy, and photodynamic therapy. Dermatol. Clin. 23(2), 199-207 (2005).
5. Vrouenraets M, Visser GW, Snow GB, Van Dongen G. Basic principles, applications in oncology and improved selectivity of photodynamic therapy. Anticancer Res. 23(1), 505-522 (2003).
6. Kormeili T, Yamauchi PS, Lowe NJ. Topical photodynamic therapy in clinical dermatology. Br. J. Dermatol. 150(6), 1061-1069 (2004).
7. Kurwa HA, Barlow RJ. The role of photodynamic therapy in dermatology. Clin. Exp. Dermatol. 24(3), 143-148 (1999).
8. Kalka K, Merk H, Mukhtar H. Photodynamic therapy in dermatology. J. Am. Acad. Dermatol. 42(3), 389-413 (2000).
9. Dennis EJ, Dolmans G J, Fukura D, Kain R. Photodynamic therapy for cancer. Nature Rev. Cancer 3(1), 380-387 (2003).
10. Taylor EL, Brown SB. The advantages of aminolevulinic acid photodynamic therapy in dermatology. J. Dermatolog. Treat. 13(Suppl. 1), S3-S11 (2002).
11. Stepleton M, Rhodes LE. Photosensitizers for photodynamic therapy for cutaneous disease. J. Dermatolog. Treat. 14(1), 107-112 (2003).
12. Brown SB, Brown EA, Walker I. The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol. 5(8), 497-508 (2004).
13. Gollnick SO, Lui X, Owczarczak B, Musser D. Altered expression of interleukin-6 and interleukin-10 as a result of photodynamic therapy in vivo. Cancer Res. 57(1), 3904-3909 (1997).
14. Sibata CH, Colussi VC, Oleinick NL, Kinsella TJ. Photodynamic therapy in oncology. Expert Opin. Pharmacother. 2(16), 917-927 (2001).
15. Karrer S, Szeimies RM, Hohenleutner U, Landthaler M. Role of lasers and photodynamic therapy in the treatment of cutaneous malignancy. Am. J. Clin. Dermatol. 2(4), 229-237 (2001).
16. Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J. Photochem. Photobiol. 6(1), 143-148 (1990).
17. Morton CA. The emerging role of 5-ALA PDT in dermatology: is PDT superior to standard treatments? J. Dermatolog. Treat. 13(Suppl. 1), S25-299 (2002).
18. Calin MA, Gruia M, Herascu N, Coman T. The monitoring of the accumulation of protoporphyrin IX in Walker tumours by subcutaneous administration of delta-aminolevulinic acid. J. Exp. Ther. Oncol. 4(3), 247-251 (2004).
19. Rud E, Gederaas O, Hosget A. 5-aminolevulinic acid but not 5-aminolevulinic acid esters, is transported into adenocarcinoma cells by the BETA transporters. Photochem. Photobiol. 71(1), 640-645 (2000).
20. Fritsch C, Homey B, Stahl W. Preferential porphyrin enrichment in solar keratoses upon topical application of delta aminolevulininc acid methylester. Photochem. Photobiol. 68, 218-221 (1998).
21. Kurwa HA, Yong-Gee SA, Seed PT. A randomized paired comparison of photodynamic therapy and topical 5-fluorouracil in the treatment of actinic keratoses. J. Am. Acad. Dermatol. 41, 414-418 (1999).
22. Jeffes EW. Photodynamic therapy of actinic keratoses with topical aminolevulinic acid hydrochloride and fluorescent blue light. J. Am. Acad. Dermatol. 45, 96-104 (2001).
23. Jeffes EW. Levulan: the first approved topical photosensitizer for the treatment of acticic keratoses. J. Dermatol. Treat. 13(Suppl. 1), S19-523 (2002).
24. Freeman M. A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective randomized study. J. Dermatol. Treat. 14, 99-106 (2003).
25. Parisier DM. Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial. J. Am. Acad. Dermatol. 48, 227-232 (2003).
26. Morton CA. Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease. Br. J. Dermatol. 135, 766-771 (1996).
27. Salim A, Leman JA, McColl JH, Chapman R, Morton CA. Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen's disease. Br. J. Dermatol. 148(3), 539-543 (2003).
28. Svanberg K. Photodynamic therapy of non-melanoma malignant tumors of the skin using topical delta-amino levulinic acid sensitization and laser irradiation. Br. J. Dermatol. 130, 743-751 (1994).
29. Lui H. Photodynamic therapy and non-melanoma skin cancer with topical aminolevulinic acid: a clinical and histologic study. Arch. Dermatol. 131(1), 737-738 (1995).
30. Choudry K, Brooke RC, Farrar W, Rhodes LE. The effect of an iron chelating agent on protoporphyrin IX levels and phototoxicity in topical 5-aminolaevulinic acid photodynamic therapy. Br. J. Dermatol. 149(1), 124-30 (2003).
31. Soler AM, Warloe T, Berner A, Giercksky KE. A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage. Br. J. Dermatol. 145, 467-471 (2001).
32. Morton CA, Brown SB, Collins S et al. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br. J. Dermatol. 146, 552-567 (2002).
33. Bolgnia J, Jorizzo J, Rapini R. Photodynamic therapy. In: Dermatology. Volume 2. 135, 2127-2142, Mosby (2003).
34. Knobler E. Current management strategies for cutaneous T-cell lymphoma. Clin. Dermatol. 22(3), 197-208 (2004).
35. Coors EA, von den Driesch P. Topical photodynamic therapy for patients with therapy-resistant lesions of cutaneous T-cell lymphoma. J. Am. Acad. Dermatol. 50(3), 363-367 (2004).
36. Oleinick N, Antunez A, Clay M, Rihter B, Kenney M. New phthalocyanine photosensitizers for photodynamic therapy. Photochem. Photobiol. 57, 242-247 (1993).
37. Ke M, Liang-yan X, Azzizudin K et al. Uptake of the silicon phthalocyanine Pc 4 and increased photodynamic sensitivity for Jurkat T-cells versus A431 epidermoid cells (2005) (In Press).
38. Usuda J, Azizzudin K, Chiu SM, Oleinick NL. Association between the photodynamic loss of Bcl-2 and the sensitivity to apoptosis caused by phthalocyanine photodynamic therapy. Photochem. Photobiol. 78(1), 1-8 (2003).
39. Swick AR, Camouse M, McCormick TS et al. Succesful penetration of topically-applied silicon phthalocyanine photosensitizer Pc 4 and new Pc 4 salts into human skin. J. Invest. Dermatol. 122, A146 (2004) (Abstract).
40. Taub AF. Photodynamic therapy for the treatment of acne: a pilot study. J. Drugs Dermatol. 3(Suppl. 6), S10-S14 (2004).
41. Itoh Y, Ninomiya S, Ishibashi A. Photodynamic therapy for acne vulgaris with topical S-aminolevulinic acid. Arch. Dermatol. 136, 1093-1095 (2000).
42. Itoh Y, Ninomiya Y, Tajima S, Ishibashi A. Photodynamic therapy of acne vulgaris with topical delta aminolevulininc acid and incoherent light in Japanese patients. Br. J. Dermatol. 144, 575-579 (2001).
43. Hongcharu W. Taylor CR, Chang Y. Topical ALA-photodynamic therapy for the treatment of acne vulgaris. J. Invest. Dermatol. 115, 183-192 (2000).
44. Goldman MP, Boyce SM. A single center study of aminolevulinic acid and 417 nm photodynamic therapy in the treatment of moderate to severe acne vulgaris. J. Invest. Dermatol. 2, 393-396 (2003).
45. Elman M, Slatkine M, Harth Y. The effective treatment of acne vulgaris by a high intensity narrow band 405-420 nm light source. J. Cosmet Laser Ther. 5, 111-117 (2003).
46. Touma DJ, Guilchrest BA. Topical photodynamic therapy: a new tool in cosmetic dermatology. Semin. Cutan. Med. Surg. 22, 124-130 (2003).